Drug intelligence / Profile preview

e-e-desogestrel + e-e-etonogestrel

Development stage
Unknown
Lead developer
Organon
Modality
Small Molecules
Administration
Oral, Subdermal, Intravaginal
01

Overview

This is a combination of two progestins, desogestrel and etonogestrel, both in their 11-methylene (E-E) forms. Desogestrel is a third-generation synthetic progestin used primarily in oral contraceptives, where it acts as a progesterone receptor agonist to inhibit ovulation and alter cervical mucus and endometrial lining to prevent pregnancy[6][8]. Etonogestrel is the biologically active metabolite of desogestrel and is also used as a contraceptive agent, most notably in subdermal implants or vaginal rings[5][7]. Both drugs act by suppressing the hypothalamic-pituitary-gonadal axis, thereby inhibiting gonadotropin secretion (luteinizing hormone and follicle-stimulating hormone), which prevents ovulation. They also increase cervical mucus viscosity to impede sperm penetration and induce endometrial changes that reduce the likelihood of implantation[2][3][7]. This specific combination (desogestrel + etonogestrel) does not correspond to any approved pharmaceutical product; typically, each drug is combined with an estrogen such as ethinyl estradiol for contraceptive use.

02

Targets

ER (Estrogen receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on e-e-desogestrel + e-e-etonogestrel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on e-e-desogestrel + e-e-etonogestrel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call